Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Der Pathologe|November 6, 2020
[Invariant natural killer T cells : Cellular immune regulators with cytotoxic potential]Dominik Schneidawind
Plos One|December 24, 2015
Freeze and Thaw of CD4+CD25+Foxp3+ Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host DiseaseMareike Florek, Dominik Schneidawind, Antonio Pierini, et al.
Blood|July 2, 2016
TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatmentAntonio Pierini, William Strober, Caitlin Moffett, et al.
Blood|July 18, 2014
Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host modelsMareike Florek, Emanuela I Sega, Dennis B Leveson-Gower, et al.
Blood|September 27, 2013
Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantationDominik Schneidawind, Antonio Pierini, Robert S Negrin
Current Stem Cell Reports|January 19, 2016
Regulatory T Cell Immunotherapy in Immune-Mediated DiseasesAntonio Pierini, Dominik Schneidawind, Hidekazu Nishikii, et al.
Frontiers in Immunology|May 8, 2026
Extracorporeal photopheresis alone or in combination with ruxolitinib for the treatment of chronic graft-versus-host diseaseChristian Koch, Markus G Manz, Mirjam Nägeli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 17, 2024
Extracorporeal cytokine adsorption as therapeutic option for immune effector cell-associated neurotoxicity syndromeAlix Buhlmann, Emanuel Rom, Giovanna Schweiger, et al.
Annals of Hematology|August 2, 2018
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemiaCorina Schneidawind, Volker Hagmaier, Christoph Faul, et al.
Annals of Hematology|May 9, 2013
Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemiaDominik Schneidawind, Birgit Federmann, Christoph Faul, et al.
Pageof 11